Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

    • OpenAI

    - PMLiVE

    Lilly announces new study data on Inluriyo in metastatic breast cancer

    The five-year survival rate for metastatic breast cancer is 30%

    - PMLiVE

    Lilly and Indiana University collaborate to expand clinical trial access

    The five-year agreement includes a focus on R&D for Alzheimer’s disease

    - PMLiVE

    Lilly announces plans for $6bn US manufacture facility

    The site is the third of four new US sites that Lilly has announced

    Amiculum's Aaron Fletcher smiling to camera on the left, with text on the right that reads 'AI persona generation'

    AI persona generation for healthcare: quick wins & real-world impact

    By Aaron Fletcher

    Amiculum

    VuuAI and Amiculum

    VuuAI and Amiculum partner to transform content engagement in pharma

    Amiculum, a global health communications agency, has entered into an exciting strategic collaboration with VuuAI, a GenAI-driven content production automation platform. The collaboration is designed to optimize the deployment of...

    Amiculum

    - PMLiVE

    Does real-world use of AI in systematic literature reviews result in time and cost savings?

    By Manca Povsic and Emma Griffiths

    Amiculum

    - PMLiVE

    Inizio launches InConcert™ to transform pre-launch planning through connected intelligence.

    Inizio today announced the launch of InConcert™, a new AI-powered data solution designed to accelerate smarter, evidence-led decisions during the critical pre-launch phase of the product lifecycle.

    Inizio

    - PMLiVE

    Scientists uncover new drug target in fight against antimicrobial resistance

    The discovery could lead to improved treatments for bacterial infections

    - PMLiVE

    Lilly and MeiraGTx partner in $475m ophthalmology deal

    The companies will develop and commercialise therapies for genetic conditions

    - PMLiVE

    Lilly announces agreement with US government to lower patient costs

    The agreement will make insulin and obesity treatments more affordable through federal programmes and direct-to-patient channels

    - PMLiVE

    Lilly announces plan for new $3bn facility to boost manufacturing in Europe

    The facility will be built in the Netherlands and will increase capacity for the company's oral medicines portfolio

    - PMLiVE

    Lilly to invest $1.2bn in Puerto Rico manufacturing site

    The investment will strengthen Lilly’s US manufacturing network

    Subscribe to our email news alerts

    Latest content

    Latest intelligence

    Quick links